Frank T. Watkins - 20 Jul 2021 Form 4 Insider Report for Shockwave Medical, Inc.

Role
Director
Signature
/s/ Wade Estey, as attorney-in-fact for Frank T. Watkins
Issuer symbol
N/A
Transactions as of
20 Jul 2021
Net transactions value
-$340,397
Form type
4
Filing time
21 Jul 2021, 19:49:25 UTC
Previous filing
09 Jul 2021
Next filing
22 Jul 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Sale $20,660 -124 -0.16% $166.61 75,678 20 Jul 2021 Direct F1, F2
transaction SWAV Common Stock Sale $24,781 -148 -0.2% $167.44 75,530 20 Jul 2021 Direct F3
transaction SWAV Common Stock Sale $3,559 -21 -0.03% $169.46 75,509 20 Jul 2021 Direct F4
transaction SWAV Common Stock Sale $120,473 -708 -0.94% $170.16 74,801 20 Jul 2021 Direct F5
transaction SWAV Common Stock Sale $161,462 -944 -1.3% $171.04 73,857 20 Jul 2021 Direct F6
transaction SWAV Common Stock Sale $9,463 -55 -0.07% $172.05 73,802 20 Jul 2021 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on November 16, 2020.
F2 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $165.77 to $166.72. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $166.80 to $167.62. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F4 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $168.45 to $169.51. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F5 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $169.52 to $170.51. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F6 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $170.53 to $171.51. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F7 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $171.71 to $172.41. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.